Recent breakthroughs in the management of locally advanced and recurrent/metastatic cervical cancer
Author:
Affiliation:
1. University California, Irvine, Medical Center, Orange, CA, USA.
2. Adventist Health White Memorial, Medical Center, Los Angeles, CA, USA.
Publisher
XMLink
Subject
Obstetrics and Gynecology,Oncology,General Medicine
Link
https://ejgo.org/pdf/10.3802/jgo.2024.35.e30
Reference34 articles.
1. LBA8 A randomised phase III trial of induction chemotherapy followed by chemoradiation compared with chemoradiation alone in locally advanced cervical cancer: The GCIG INTERLACE trial
2. ENGOT-cx11/KEYNOTE-A18: A phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer.
3. Pembrolizumab + chemotherapy in patients with persistent, recurrent, or metastatic cervical cancer: Subgroup analysis of KEYNOTE-826.
4. Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The prognostic value of Th17/Treg cell in cervical cancer: a systematic review and meta-analysis;Frontiers in Oncology;2024-09-11
2. Pharmacokinetics and pharmacodynamics of angiogenesis inhibitors used to treat cervical cancer: current and future;Expert Opinion on Drug Metabolism & Toxicology;2024-09-09
3. Are we making progress in curing advanced cervical cancer—again?;International Journal of Gynecologic Cancer;2024-07-10
4. Causal role of immune cells on cervical cancer onset revealed by two-sample Mendelian randomization study;Scientific Reports;2024-06-28
5. A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04);International Journal of Gynecologic Cancer;2024-06-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3